Deposit your data and get a DOI
Upload a data set with its description. A person reviews it before it is published.
Research data
From 2021 to 2025, 12,400 animal research papers mentioned a behavioral test and one of these 53 animal models, from drugs and surgery to stress and diet.
The tests paired with each animal model. Behavioral tests are on the left and animal models on the right, grouped as in the grid below. A line joins a test to an animal model when 30 or more papers on that animal model from 2021 to 2025 mention the test.
Tap or click a dot to highlight its lines. Tap or click it again to open its page.
Each row is an animal model. Each column is a test in the top three for at least one model. A cell takes the model's papers that mention any of the 90 behavioral tests we count and gives the percent that mention the column's test. The darker the cell, the higher the percent.
All 53 animal models, sorted by the test each mentions most.
Hover over or tap a cell to see its counts; a click opens the page on that pair, or on the model where the pair has none. Click a test's name to sort the animal models by it; the arrow keys move between cells.
| Of each model's papers that mention a test, the percent that mention each test | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Model | Papers with a test | ||||||||||||||||||||||||||||||||
| Drugs and toxins | |||||||||||||||||||||||||||||||||
| Streptozotocin diabetes | 510 | 35% | 8% | 10% | 11% | 8% | 1% | 2% | 2% | 7% | 0% | 0.4% | 0% | 0.4% | 11% | 6% | 3% | 0.6% | 13% | 5% | 5% | 0.8% | 0.6% | 0.2% | 0% | 0.2% | 0% | 0% | 0% | 0% | 9% | 1% | 0% |
| Scopolamine | 483 | 46% | 32% | 28% | 9% | 4% | 0.6% | 2% | 2% | 28% | 0% | 0% | 0% | 0% | 0.2% | 0% | 0% | 0% | 0.4% | 1% | 0.6% | 0.2% | 0.4% | 1% | 0% | 0% | 0% | 0.2% | 0.2% | 0% | 6% | 0% | 0.8% |
| D-galactose | 244 | 64% | 15% | 18% | 4% | 2% | 1% | 2% | 3% | 7% | 0% | 0% | 0.4% | 0% | 0% | 0% | 0% | 0.4% | 4% | 0.8% | 9% | 0.4% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 9% | 0% | 0% |
| Streptozotocin in the brain (ICV-STZ) | 174 | 65% | 16% | 30% | 7% | 2% | 2% | 1% | 2% | 25% | 0% | 0% | 0.6% | 0% | 0% | 0% | 0.6% | 0% | 1% | 1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 8% | 0% | 0.6% |
| Kainic acid or pilocarpine seizures | 161 | 37% | 11% | 19% | 12% | 6% | 4% | 3% | 2% | 6% | 0% | 0% | 0% | 0.6% | 0.6% | 0.6% | 0% | 0% | 1% | 10% | 1% | 0.6% | 1% | 0.6% | 0.6% | 0% | 0.6% | 0.6% | 0% | 0% | 12% | 1% | 0% |
| Aluminum chloride | 157 | 61% | 20% | 20% | 18% | 3% | 0% | 1% | 0.6% | 13% | 0% | 0% | 0.6% | 0% | 0% | 0% | 0% | 0% | 0% | 4% | 0.6% | 0% | 1% | 0% | 0% | 0.6% | 0% | 0% | 0% | 0% | 11% | 0% | 0.6% |
| Radiation exposure | 125 | 25% | 9% | 23% | 13% | 10% | 0.8% | 3% | 6% | 6% | 0% | 0% | 0% | 5% | 0.8% | 0% | 0% | 0% | 2% | 6% | 2% | 0.8% | 2% | 0% | 0.8% | 0% | 0% | 0% | 0% | 0% | 18% | 3% | 0.8% |
| Pentylenetetrazole (PTZ) | 212 | 18% | 13% | 12% | 25% | 10% | 0.9% | 8% | 0.9% | 18% | 0% | 0.5% | 0.5% | 0.5% | 0.5% | 2% | 3% | 3% | 0.5% | 19% | 2% | 0% | 0.5% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 20% | 0.5% | 0.5% |
| Lipopolysaccharide (LPS) | 876 | 22% | 13% | 12% | 10% | 23% | 13% | 15% | 4% | 5% | 0.3% | 0.6% | 1% | 2% | 3% | 2% | 1% | 2% | 2% | 5% | 3% | 0.6% | 1% | 0.3% | 0.2% | 1% | 0.2% | 0.2% | 0% | 0.1% | 21% | 0.8% | 0.8% |
| Chronic corticosterone | 109 | 7% | 2% | 4% | 20% | 50% | 32% | 28% | 10% | 6% | 0% | 0% | 3% | 0% | 0% | 0% | 0% | 0% | 0% | 2% | 0.9% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 27% | 0% | 2% |
| Reserpine | 109 | 9% | 3% | 5% | 10% | 48% | 6% | 17% | 0% | 0% | 0% | 0% | 0% | 0% | 15% | 7% | 2% | 2% | 0.9% | 9% | 2% | 0% | 2% | 18% | 0% | 0% | 0% | 0% | 0% | 0% | 28% | 0% | 0.9% |
| Prenatal valproic acid | 149 | 17% | 9% | 14% | 19% | 2% | 0.7% | 0.7% | 0.7% | 4% | 0% | 0% | 19% | 28% | 0.7% | 4% | 0% | 0% | 3% | 3% | 0.7% | 0% | 1% | 0% | 0% | 0% | 0.7% | 0% | 0% | 0% | 19% | 0.7% | 3% |
| Chemotherapy drugs | 323 | 10% | 10% | 10% | 6% | 3% | 2% | 0.6% | 2% | 5% | 0% | 0.9% | 0% | 0% | 35% | 14% | 4% | 2% | 5% | 10% | 8% | 0.9% | 0.3% | 0% | 0% | 0.3% | 0% | 0% | 0.3% | 0% | 7% | 6% | 0.6% |
| Complete Freund's adjuvant (CFA) | 216 | 0.9% | 1% | 3% | 11% | 9% | 5% | 5% | 0% | 0.5% | 0% | 2% | 0% | 0.5% | 42% | 14% | 9% | 7% | 0.9% | 3% | 3% | 4% | 0% | 0.9% | 0% | 0% | 0% | 0% | 0% | 0% | 13% | 5% | 0% |
| Monosodium iodoacetate | 69 | 1% | 0% | 3% | 1% | 1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 39% | 6% | 1% | 9% | 14% | 7% | 9% | 13% | 1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 4% | 1% | 1% |
| Carrageenan | 317 | 0.3% | 0.6% | 0% | 2% | 2% | 0.6% | 0.9% | 0% | 0.3% | 0.3% | 0% | 0% | 0% | 10% | 38% | 32% | 49% | 0% | 7% | 0% | 0% | 0% | 0.6% | 0% | 0% | 0% | 0% | 0% | 0% | 5% | 0% | 0.3% |
| 6-OHDA | 255 | 6% | 2% | 5% | 7% | 6% | 5% | 2% | 0% | 3% | 0% | 0.4% | 0% | 0.8% | 4% | 1% | 1% | 0% | 9% | 24% | 4% | 5% | 5% | 7% | 13% | 4% | 0% | 16% | 1% | 0% | 20% | 2% | 0.8% |
| MPTP | 249 | 5% | 4% | 2% | 3% | 5% | 2% | 2% | 0.4% | 1% | 0% | 0% | 0% | 0.4% | 0% | 0.4% | 0% | 0% | 5% | 51% | 4% | 8% | 9% | 5% | 1% | 28% | 0% | 1% | 0% | 0% | 33% | 0.4% | 0% |
| Rotenone | 160 | 4% | 8% | 5% | 3% | 6% | 6% | 3% | 0.6% | 0.6% | 0% | 0.6% | 0% | 0% | 0% | 0% | 0% | 0% | 0.6% | 45% | 11% | 6% | 11% | 19% | 4% | 5% | 0% | 0% | 0% | 0% | 25% | 0% | 0% |
| Cuprizone | 85 | 6% | 26% | 6% | 7% | 5% | 4% | 8% | 1% | 4% | 0% | 0% | 0% | 0% | 1% | 1% | 0% | 0% | 6% | 36% | 11% | 1% | 11% | 0% | 0% | 5% | 1% | 0% | 0% | 0% | 15% | 2% | 0% |
| 3-Nitropropionic acid (3-NP) | 38 | 8% | 8% | 11% | 16% | 3% | 0% | 0% | 0% | 3% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 61% | 21% | 3% | 34% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 26% | 0% | 0% |
| Haloperidol | 135 | 3% | 1% | 7% | 3% | 13% | 3% | 5% | 4% | 3% | 0% | 2% | 0.7% | 0% | 1% | 3% | 1% | 1% | 0.7% | 15% | 1% | 0.7% | 4% | 44% | 0% | 0.7% | 0% | 3% | 0.7% | 0% | 14% | 0.7% | 8% |
| MK-801 | 190 | 15% | 11% | 23% | 9% | 6% | 2% | 5% | 6% | 7% | 0% | 1% | 4% | 2% | 2% | 0.5% | 2% | 0.5% | 0% | 2% | 0.5% | 0% | 0.5% | 8% | 0% | 0% | 0% | 1% | 0% | 0% | 16% | 0% | 28% |
| Maternal immune activation | 103 | 4% | 6% | 16% | 14% | 6% | 3% | 0% | 6% | 1% | 1% | 1% | 9% | 13% | 0% | 0% | 0% | 0% | 0% | 4% | 2% | 0% | 1% | 0% | 0% | 1% | 0% | 0% | 0% | 0% | 19% | 1% | 40% |
| Surgery | |||||||||||||||||||||||||||||||||
| Middle cerebral artery occlusion (MCAO) | 494 | 30% | 3% | 8% | 3% | 5% | 6% | 2% | 1% | 2% | 0% | 0% | 0.4% | 0% | 0% | 0% | 0% | 0% | 7% | 23% | 7% | 6% | 10% | 0% | 4% | 1% | 8% | 0.2% | 2% | 5% | 12% | 2% | 0% |
| Traumatic brain injury | 334 | 36% | 7% | 13% | 8% | 5% | 2% | 2% | 6% | 1% | 0% | 0.3% | 1% | 0.9% | 2% | 0.3% | 0% | 0% | 1% | 18% | 3% | 3% | 16% | 0% | 1% | 0.3% | 2% | 0.3% | 0% | 0.6% | 13% | 2% | 0.9% |
| Carotid artery occlusion (BCCAO, 2VO) | 264 | 70% | 14% | 22% | 2% | 2% | 2% | 2% | 0.8% | 7% | 0% | 0% | 0.4% | 0% | 0.4% | 0% | 0% | 0% | 3% | 4% | 3% | 0.4% | 0.8% | 0% | 0% | 0.8% | 0.8% | 0% | 0% | 0% | 9% | 3% | 0% |
| Sepsis | 161 | 47% | 20% | 25% | 11% | 5% | 0.6% | 8% | 19% | 4% | 0% | 0% | 0% | 0.6% | 0% | 0.6% | 0.6% | 0.6% | 2% | 0.6% | 4% | 0% | 0% | 0% | 0% | 0.6% | 0% | 0% | 0% | 0% | 25% | 0% | 0% |
| Neonatal hypoxia-ischemia | 125 | 43% | 8% | 16% | 4% | 2% | 0.8% | 0% | 0.8% | 0% | 0% | 0% | 0.8% | 2% | 0% | 0% | 0% | 0% | 2% | 17% | 10% | 5% | 3% | 0% | 7% | 0% | 2% | 0% | 0% | 0% | 13% | 0.8% | 0% |
| Subarachnoid hemorrhage | 64 | 39% | 14% | 13% | 2% | 3% | 2% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 38% | 2% | 3% | 27% | 0% | 2% | 3% | 5% | 0% | 0% | 3% | 19% | 0% | 0% |
| Ovariectomy | 309 | 16% | 7% | 10% | 13% | 18% | 7% | 7% | 4% | 3% | 1% | 4% | 1% | 0.6% | 4% | 1% | 1% | 0.3% | 13% | 1% | 6% | 0% | 0.3% | 0% | 0.3% | 0% | 0% | 1% | 0% | 0% | 12% | 5% | 1% |
| Olfactory bulbectomy | 35 | 11% | 11% | 11% | 11% | 14% | 17% | 14% | 6% | 9% | 0% | 11% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 3% | 0% | 14% | 0% | 0% |
| Nerve injury | 485 | 1% | 1% | 4% | 7% | 5% | 2% | 3% | 1% | 0.4% | 0% | 0.8% | 0% | 0.2% | 49% | 12% | 7% | 3% | 4% | 8% | 2% | 8% | 0.8% | 0% | 0% | 0% | 0.6% | 0% | 0% | 0% | 8% | 2% | 0% |
| Intracerebral hemorrhage | 114 | 16% | 8% | 3% | 2% | 4% | 3% | 3% | 0.9% | 0% | 0% | 0% | 0% | 0.9% | 0% | 0% | 0% | 0% | 8% | 26% | 4% | 2% | 5% | 0% | 11% | 0.9% | 10% | 0% | 3% | 20% | 12% | 0.9% | 0% |
| Spinal cord injury | 395 | 0.5% | 0.3% | 2% | 0.3% | 2% | 1% | 0.3% | 0.5% | 0% | 0% | 0% | 0% | 0% | 13% | 4% | 0.5% | 0.5% | 19% | 5% | 6% | 33% | 3% | 0.3% | 1% | 0% | 5% | 0% | 3% | 0% | 11% | 2% | 0.3% |
| Photothrombotic stroke | 87 | 9% | 1% | 7% | 5% | 3% | 2% | 6% | 0% | 5% | 0% | 0% | 2% | 0% | 0% | 0% | 0% | 0% | 5% | 11% | 3% | 2% | 5% | 0% | 21% | 0% | 29% | 0% | 18% | 0% | 6% | 2% | 0% |
| Stress | |||||||||||||||||||||||||||||||||
| Chronic unpredictable stress | 973 | 9% | 2% | 5% | 17% | 59% | 59% | 31% | 0.9% | 1% | 0.5% | 0.1% | 2% | 0.6% | 0.1% | 0.7% | 0% | 0.2% | 1% | 0.4% | 0.4% | 0% | 0.3% | 0% | 0% | 0.1% | 0.1% | 0% | 0% | 0% | 39% | 0.5% | 0.2% |
| Restraint stress | 553 | 6% | 3% | 6% | 28% | 34% | 18% | 18% | 5% | 3% | 2% | 2% | 1% | 0.5% | 2% | 1% | 0.9% | 0% | 3% | 0.5% | 0.5% | 0% | 0% | 0.4% | 0% | 0% | 0% | 0% | 0% | 0% | 25% | 2% | 2% |
| Maternal separation and early-life stress | 343 | 8% | 3% | 6% | 24% | 27% | 17% | 7% | 8% | 4% | 1% | 4% | 4% | 4% | 0.6% | 0% | 0.3% | 0% | 0.6% | 0.3% | 0.6% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 21% | 3% | 6% |
| Social defeat stress | 304 | 2% | 0.7% | 4% | 18% | 30% | 22% | 18% | 6% | 0.7% | 0.7% | 5% | 23% | 2% | 1% | 0% | 0.3% | 0% | 0.7% | 0.7% | 0.3% | 0.3% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 16% | 2% | 2% |
| Single prolonged stress | 142 | 6% | 6% | 4% | 44% | 20% | 2% | 6% | 49% | 1% | 0.7% | 0.7% | 0.7% | 0.7% | 2% | 0% | 0% | 0% | 2% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 20% | 0% | 2% |
| Predator stress | 206 | 1% | 1% | 4% | 19% | 4% | 3% | 1% | 9% | 0% | 83% | 4% | 2% | 1% | 0% | 0% | 0% | 0% | 0.5% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 8% | 0.5% | 9% |
| Social isolation | 276 | 9% | 6% | 10% | 18% | 19% | 9% | 5% | 5% | 5% | 0.4% | 7% | 8% | 7% | 0.7% | 1% | 0.4% | 0% | 1% | 0.4% | 0.4% | 0% | 0.4% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 21% | 5% | 6% |
| Diet, sleep, exercise and housing | |||||||||||||||||||||||||||||||||
| High-fat diet | 868 | 22% | 8% | 12% | 9% | 5% | 5% | 3% | 2% | 3% | 0.1% | 0.9% | 0.6% | 0.5% | 2% | 0.3% | 0% | 0% | 21% | 2% | 8% | 0.3% | 0.5% | 0% | 0% | 0.2% | 0.3% | 0% | 0% | 0.2% | 11% | 10% | 0.2% |
| Sleep deprivation | 306 | 32% | 11% | 15% | 15% | 13% | 7% | 8% | 7% | 7% | 0.7% | 3% | 1% | 1% | 0% | 1% | 0.7% | 0% | 4% | 5% | 2% | 0.3% | 0.7% | 0.3% | 0% | 0.3% | 0% | 0% | 0.3% | 0% | 23% | 0.7% | 1% |
| Environmental enrichment | 295 | 24% | 5% | 16% | 18% | 10% | 5% | 4% | 7% | 5% | 1% | 8% | 3% | 1% | 1% | 1% | 0.3% | 0% | 4% | 4% | 1% | 0.3% | 3% | 0% | 0.7% | 0% | 0% | 0% | 0.7% | 0% | 12% | 8% | 1% |
| Gut microbiota depletion or transplant | 166 | 19% | 8% | 13% | 13% | 12% | 7% | 7% | 4% | 0.6% | 0% | 3% | 1% | 2% | 1% | 0% | 0.6% | 0% | 4% | 5% | 5% | 0.6% | 1% | 0% | 0% | 0.6% | 0% | 0% | 0% | 0% | 12% | 5% | 1% |
| Intermittent or chronic hypoxia | 113 | 48% | 12% | 13% | 11% | 9% | 4% | 3% | 2% | 2% | 0% | 0% | 0% | 0.9% | 0% | 0% | 0% | 0% | 9% | 10% | 3% | 0.9% | 3% | 0% | 0% | 0.9% | 0% | 0% | 0.9% | 0% | 18% | 2% | 0.9% |
| Ketogenic diet | 52 | 25% | 10% | 15% | 8% | 4% | 4% | 4% | 0% | 2% | 0% | 4% | 4% | 0% | 4% | 0% | 0% | 0% | 12% | 12% | 10% | 0% | 2% | 0% | 0% | 0% | 2% | 4% | 0% | 0% | 10% | 2% | 0% |
| Calorie restriction and fasting | 120 | 9% | 6% | 13% | 16% | 8% | 3% | 3% | 2% | 3% | 0.8% | 2% | 0.8% | 0% | 0% | 0% | 0.8% | 0% | 13% | 3% | 8% | 0.8% | 0.8% | 0% | 0.8% | 0% | 0% | 0% | 0% | 0.8% | 14% | 11% | 2% |
| Chronic intermittent ethanol (CIE) | 58 | 7% | 2% | 3% | 12% | 19% | 3% | 3% | 9% | 0% | 2% | 28% | 0% | 0% | 5% | 0% | 0% | 0% | 2% | 2% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 10% | 0% | 0% |
| Exercise | 916 | 17% | 4% | 9% | 9% | 13% | 4% | 4% | 3% | 4% | 0.1% | 0.4% | 0.7% | 0.4% | 3% | 0.8% | 0.3% | 0.1% | Not counted | 12% | 20% | 4% | 3% | 0.1% | 0.8% | 0.3% | 1% | 0.2% | 0.3% | 0.1% | 12% | Not counted | 0.1% |
| Circadian disruption | 66 | 6% | 9% | 17% | 8% | 8% | 11% | 2% | 0% | 2% | 2% | 0% | 5% | 0% | 0% | 0% | 0% | 0% | 0% | 3% | 2% | 0% | 2% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 18% | 32% | 5% |
Each chart counts the papers a year that mention the animal model and a behavioral test, from 2001 to 2026; the count for 2026 covers only part of the year. The change on each chart compares 2021 to 2025 with 2011 to 2015. Each chart has its own scale, so the line shows the shape of the change; choose Same scale to compare the counts themselves.
The 12 animal models with the most papers, of 53, each chart on its own scale.
973 papers, 2021 to 2025
2.1 times as many
916 papers, 2021 to 2025
1.9 times as many
876 papers, 2021 to 2025
2.8 times as many
868 papers, 2021 to 2025
2.7 times as many
553 papers, 2021 to 2025
1.3 times as many
510 papers, 2021 to 2025
1.7 times as many
Middle cerebral artery occlusion (MCAO)
494 papers, 2021 to 2025
2.1 times as many
485 papers, 2021 to 2025
1.3 times as many
483 papers, 2021 to 2025
1.2 times as many
395 papers, 2021 to 2025
1.2 times as many
Maternal separation and early-life stress
343 papers, 2021 to 2025
1.6 times as many
334 papers, 2021 to 2025
1.4 times as many
323 papers, 2021 to 2025
2.5 times as many
317 papers, 2021 to 2025
31% fewer
309 papers, 2021 to 2025
about the same
306 papers, 2021 to 2025
2.3 times as many
304 papers, 2021 to 2025
1.8 times as many
295 papers, 2021 to 2025
about the same
276 papers, 2021 to 2025
1.5 times as many
Carotid artery occlusion (BCCAO, 2VO)
264 papers, 2021 to 2025
1.5 times as many
255 papers, 2021 to 2025
22% fewer
249 papers, 2021 to 2025
1.7 times as many
244 papers, 2021 to 2025
3.4 times as many
Complete Freund's adjuvant (CFA)
216 papers, 2021 to 2025
1.5 times as many
212 papers, 2021 to 2025
1.1 times as many
206 papers, 2021 to 2025
10% fewer
190 papers, 2021 to 2025
43% fewer
Streptozotocin in the brain (ICV-STZ)
174 papers, 2021 to 2025
2.3 times as many
Gut microbiota depletion or transplant
166 papers, 2021 to 2025
Too few papers to compare
Kainic acid or pilocarpine seizures
161 papers, 2021 to 2025
1.5 times as many
161 papers, 2021 to 2025
6.2 times as many
160 papers, 2021 to 2025
5.0 times as many
157 papers, 2021 to 2025
4.0 times as many
149 papers, 2021 to 2025
3.9 times as many
142 papers, 2021 to 2025
3.5 times as many
Haloperidol
135 papers, 2021 to 2025
58% fewer
125 papers, 2021 to 2025
1.2 times as many
125 papers, 2021 to 2025
1.4 times as many
Calorie restriction and fasting
120 papers, 2021 to 2025
1.8 times as many
114 papers, 2021 to 2025
1.8 times as many
Intermittent or chronic hypoxia
113 papers, 2021 to 2025
1.4 times as many
109 papers, 2021 to 2025
about the same
109 papers, 2021 to 2025
1.3 times as many
103 papers, 2021 to 2025
2.5 times as many
Photothrombotic stroke
87 papers, 2021 to 2025
2.6 times as many
Cuprizone
85 papers, 2021 to 2025
Too few papers to compare
Monosodium iodoacetate
69 papers, 2021 to 2025
2.7 times as many
Circadian disruption
66 papers, 2021 to 2025
1.5 times as many
Subarachnoid hemorrhage
64 papers, 2021 to 2025
2.7 times as many
Chronic intermittent ethanol (CIE)
58 papers, 2021 to 2025
1.7 times as many
Ketogenic diet
52 papers, 2021 to 2025
4.0 times as many
3-Nitropropionic acid (3-NP)
38 papers, 2021 to 2025
1.2 times as many
Olfactory bulbectomy
35 papers, 2021 to 2025
54% fewer
| Animal model | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 so far |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic unpredictable stress | 4 | 6 | 8 | 12 | 24 | 13 | 26 | 48 | 42 | 49 | 66 | 62 | 91 | 117 | 121 | 118 | 162 | 165 | 164 | 190 | 189 | 194 | 184 | 179 | 227 | 205 |
| Exercise | 15 | 3 | 17 | 30 | 23 | 33 | 36 | 41 | 52 | 64 | 61 | 76 | 102 | 111 | 128 | 138 | 146 | 154 | 184 | 170 | 186 | 186 | 166 | 188 | 190 | 158 |
| Lipopolysaccharide (LPS) | 14 | 11 | 6 | 20 | 24 | 29 | 26 | 30 | 31 | 38 | 52 | 40 | 64 | 70 | 87 | 92 | 104 | 132 | 150 | 145 | 157 | 169 | 171 | 183 | 196 | 192 |
| High-fat diet | 5 | 3 | 3 | 8 | 8 | 6 | 12 | 12 | 26 | 38 | 37 | 52 | 59 | 69 | 110 | 111 | 136 | 121 | 132 | 155 | 155 | 180 | 154 | 170 | 209 | 175 |
| Restraint stress | 14 | 34 | 30 | 48 | 37 | 42 | 38 | 44 | 60 | 68 | 64 | 69 | 96 | 88 | 95 | 75 | 90 | 104 | 100 | 94 | 114 | 115 | 91 | 107 | 126 | 125 |
| Streptozotocin diabetes | 5 | 14 | 25 | 24 | 25 | 17 | 28 | 24 | 26 | 36 | 55 | 45 | 56 | 71 | 74 | 71 | 69 | 96 | 99 | 101 | 107 | 102 | 102 | 106 | 93 | 93 |
| Middle cerebral artery occlusion (MCAO) | 12 | 12 | 17 | 14 | 23 | 27 | 29 | 28 | 26 | 28 | 37 | 43 | 65 | 44 | 44 | 60 | 70 | 74 | 97 | 90 | 102 | 76 | 85 | 101 | 130 | 129 |
| Nerve injury | 19 | 30 | 32 | 31 | 37 | 39 | 47 | 41 | 36 | 54 | 66 | 75 | 67 | 85 | 95 | 97 | 97 | 123 | 97 | 125 | 109 | 93 | 95 | 84 | 104 | 136 |
| Scopolamine | 67 | 57 | 51 | 55 | 49 | 63 | 73 | 53 | 68 | 66 | 74 | 84 | 71 | 73 | 86 | 85 | 103 | 88 | 93 | 85 | 97 | 97 | 79 | 100 | 110 | 88 |
| Spinal cord injury | 20 | 21 | 19 | 30 | 38 | 36 | 36 | 44 | 47 | 53 | 44 | 57 | 82 | 74 | 60 | 66 | 59 | 69 | 65 | 64 | 82 | 62 | 69 | 71 | 111 | 90 |
| Maternal separation and early-life stress | 8 | 13 | 7 | 9 | 24 | 25 | 26 | 18 | 34 | 24 | 33 | 45 | 40 | 47 | 45 | 62 | 58 | 70 | 58 | 76 | 91 | 68 | 61 | 65 | 58 | 61 |
| Traumatic brain injury | 21 | 11 | 15 | 18 | 15 | 20 | 23 | 28 | 26 | 35 | 32 | 42 | 65 | 53 | 44 | 54 | 70 | 60 | 66 | 64 | 70 | 63 | 60 | 68 | 73 | 83 |
| Chemotherapy drugs | 2 | 3 | 2 | 6 | 3 | 4 | 4 | 14 | 9 | 11 | 19 | 20 | 22 | 31 | 37 | 40 | 38 | 50 | 60 | 48 | 65 | 51 | 70 | 62 | 75 | 59 |
| Carrageenan | 31 | 31 | 46 | 67 | 60 | 41 | 60 | 63 | 73 | 85 | 96 | 102 | 98 | 86 | 75 | 84 | 72 | 64 | 70 | 72 | 80 | 63 | 62 | 55 | 57 | 59 |
| Ovariectomy | 30 | 41 | 26 | 47 | 41 | 58 | 55 | 55 | 52 | 68 | 53 | 71 | 54 | 80 | 64 | 78 | 53 | 74 | 66 | 74 | 78 | 61 | 50 | 58 | 62 | 56 |
| Sleep deprivation | 5 | 4 | 5 | 15 | 13 | 7 | 13 | 16 | 20 | 21 | 27 | 16 | 33 | 27 | 33 | 29 | 38 | 38 | 41 | 52 | 45 | 60 | 54 | 68 | 79 | 81 |
| Social defeat stress | 4 | 4 | 3 | 5 | 9 | 11 | 7 | 14 | 13 | 15 | 37 | 22 | 31 | 36 | 43 | 55 | 49 | 70 | 55 | 50 | 72 | 59 | 48 | 61 | 64 | 64 |
| Environmental enrichment | 14 | 13 | 18 | 20 | 24 | 31 | 29 | 36 | 51 | 32 | 48 | 53 | 64 | 61 | 69 | 64 | 64 | 67 | 67 | 64 | 74 | 63 | 56 | 48 | 54 | 41 |
| Social isolation | 16 | 9 | 16 | 16 | 16 | 21 | 13 | 16 | 36 | 26 | 36 | 36 | 34 | 37 | 40 | 41 | 41 | 38 | 48 | 60 | 67 | 46 | 47 | 50 | 66 | 57 |
| Carotid artery occlusion (BCCAO, 2VO) | 4 | 8 | 1 | 2 | 8 | 12 | 12 | 16 | 12 | 21 | 21 | 29 | 32 | 41 | 51 | 36 | 44 | 53 | 45 | 59 | 52 | 56 | 47 | 51 | 58 | 59 |
| 6-OHDA | 53 | 38 | 43 | 48 | 68 | 53 | 59 | 52 | 45 | 50 | 48 | 73 | 62 | 61 | 83 | 62 | 68 | 62 | 74 | 56 | 61 | 47 | 34 | 55 | 58 | 47 |
| MPTP | 15 | 4 | 9 | 13 | 12 | 9 | 18 | 13 | 14 | 32 | 23 | 32 | 25 | 33 | 37 | 41 | 42 | 42 | 50 | 33 | 46 | 47 | 40 | 43 | 73 | 55 |
| D-galactose | 1 | 3 | 2 | 1 | 2 | 7 | 5 | 7 | 9 | 11 | 14 | 11 | 9 | 18 | 19 | 26 | 26 | 32 | 23 | 36 | 47 | 47 | 44 | 45 | 61 | 69 |
| Complete Freund's adjuvant (CFA) | 1 | 7 | 5 | 11 | 11 | 15 | 21 | 10 | 19 | 25 | 30 | 29 | 26 | 36 | 27 | 34 | 33 | 33 | 53 | 58 | 47 | 47 | 33 | 46 | 43 | 48 |
| Pentylenetetrazole (PTZ) | 21 | 26 | 23 | 22 | 28 | 31 | 20 | 28 | 28 | 39 | 32 | 41 | 39 | 44 | 42 | 64 | 48 | 48 | 50 | 51 | 43 | 32 | 39 | 43 | 55 | 42 |
| Predator stress | 21 | 14 | 19 | 23 | 27 | 34 | 20 | 35 | 30 | 29 | 44 | 44 | 39 | 50 | 51 | 51 | 38 | 49 | 50 | 45 | 43 | 47 | 40 | 33 | 43 | 36 |
| MK-801 | 42 | 33 | 48 | 45 | 60 | 36 | 49 | 61 | 51 | 52 | 62 | 60 | 67 | 75 | 70 | 63 | 59 | 53 | 60 | 51 | 36 | 44 | 48 | 32 | 30 | 43 |
| Streptozotocin in the brain (ICV-STZ) | 2 | 2 | 2 | 0 | 2 | 3 | 4 | 4 | 12 | 13 | 7 | 18 | 21 | 14 | 16 | 22 | 33 | 33 | 19 | 32 | 29 | 32 | 26 | 42 | 45 | 35 |
| Gut microbiota depletion or transplant | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 1 | 2 | 7 | 1 | 9 | 14 | 13 | 21 | 21 | 40 | 35 | 49 | 49 |
| Kainic acid or pilocarpine seizures | 13 | 21 | 21 | 14 | 19 | 9 | 12 | 22 | 16 | 23 | 24 | 21 | 28 | 17 | 21 | 40 | 30 | 39 | 43 | 29 | 34 | 29 | 20 | 34 | 44 | 32 |
| Sepsis | 0 | 0 | 0 | 0 | 1 | 0 | 3 | 2 | 3 | 1 | 2 | 2 | 7 | 7 | 8 | 5 | 10 | 6 | 13 | 22 | 18 | 33 | 43 | 37 | 30 | 31 |
| Rotenone | 0 | 1 | 0 | 3 | 4 | 4 | 0 | 4 | 1 | 2 | 6 | 6 | 8 | 8 | 4 | 14 | 21 | 20 | 20 | 19 | 20 | 27 | 33 | 34 | 46 | 33 |
| Aluminum chloride | 2 | 2 | 3 | 1 | 3 | 3 | 1 | 2 | 4 | 2 | 5 | 4 | 6 | 6 | 18 | 15 | 16 | 14 | 13 | 23 | 32 | 34 | 26 | 24 | 41 | 45 |
| Prenatal valproic acid | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 3 | 1 | 2 | 3 | 2 | 9 | 10 | 14 | 16 | 10 | 13 | 16 | 18 | 14 | 33 | 25 | 35 | 42 | 32 |
| Single prolonged stress | 0 | 0 | 0 | 1 | 0 | 2 | 2 | 4 | 3 | 3 | 1 | 5 | 9 | 10 | 15 | 19 | 21 | 30 | 29 | 27 | 30 | 28 | 28 | 20 | 36 | 38 |
| Haloperidol | 61 | 51 | 61 | 48 | 68 | 56 | 70 | 75 | 72 | 66 | 62 | 85 | 59 | 62 | 56 | 43 | 45 | 43 | 38 | 39 | 32 | 25 | 24 | 33 | 21 | 23 |
| Neonatal hypoxia-ischemia | 3 | 5 | 7 | 7 | 9 | 9 | 9 | 11 | 7 | 17 | 22 | 17 | 20 | 20 | 27 | 24 | 28 | 27 | 27 | 27 | 22 | 30 | 17 | 23 | 33 | 17 |
| Radiation exposure | 7 | 4 | 5 | 6 | 7 | 10 | 8 | 13 | 6 | 13 | 12 | 13 | 21 | 25 | 18 | 31 | 18 | 16 | 17 | 26 | 22 | 23 | 23 | 21 | 36 | 22 |
| Calorie restriction and fasting | 2 | 2 | 2 | 5 | 6 | 9 | 8 | 19 | 9 | 14 | 10 | 16 | 14 | 18 | 10 | 20 | 17 | 13 | 13 | 18 | 18 | 25 | 26 | 30 | 21 | 31 |
| Intracerebral hemorrhage | 2 | 2 | 3 | 2 | 9 | 11 | 7 | 7 | 12 | 11 | 13 | 15 | 12 | 8 | 17 | 11 | 14 | 12 | 15 | 21 | 20 | 21 | 19 | 25 | 29 | 34 |
| Intermittent or chronic hypoxia | 5 | 5 | 7 | 3 | 8 | 5 | 11 | 12 | 6 | 13 | 10 | 16 | 22 | 14 | 18 | 20 | 12 | 18 | 16 | 18 | 28 | 15 | 21 | 19 | 30 | 26 |
| Chronic corticosterone | 4 | 1 | 5 | 7 | 8 | 11 | 13 | 23 | 10 | 12 | 18 | 20 | 17 | 31 | 24 | 26 | 27 | 35 | 29 | 30 | 20 | 24 | 25 | 21 | 19 | 23 |
| Reserpine | 9 | 7 | 6 | 8 | 5 | 10 | 11 | 8 | 4 | 8 | 14 | 21 | 19 | 15 | 14 | 15 | 17 | 12 | 24 | 20 | 22 | 16 | 13 | 28 | 30 | 27 |
| Maternal immune activation | 0 | 0 | 1 | 0 | 2 | 2 | 2 | 2 | 3 | 4 | 8 | 7 | 7 | 11 | 9 | 10 | 7 | 14 | 12 | 15 | 24 | 17 | 26 | 19 | 17 | 26 |
| Photothrombotic stroke | 0 | 1 | 1 | 3 | 5 | 2 | 4 | 3 | 4 | 4 | 2 | 4 | 9 | 9 | 9 | 9 | 11 | 9 | 12 | 13 | 17 | 17 | 11 | 14 | 28 | 28 |
| Cuprizone | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 6 | 2 | 1 | 1 | 1 | 0 | 3 | 3 | 6 | 12 | 9 | 13 | 12 | 21 | 13 | 15 | 24 | 21 |
| Monosodium iodoacetate | 0 | 0 | 0 | 1 | 0 | 2 | 1 | 2 | 4 | 5 | 7 | 6 | 5 | 3 | 5 | 10 | 18 | 9 | 10 | 12 | 8 | 10 | 14 | 21 | 16 | 23 |
| Circadian disruption | 3 | 4 | 5 | 3 | 5 | 4 | 2 | 8 | 7 | 5 | 4 | 11 | 11 | 7 | 10 | 3 | 7 | 6 | 9 | 5 | 13 | 5 | 13 | 10 | 25 | 10 |
| Subarachnoid hemorrhage | 1 | 1 | 0 | 0 | 2 | 0 | 1 | 3 | 2 | 1 | 6 | 1 | 6 | 7 | 4 | 10 | 10 | 9 | 5 | 11 | 10 | 10 | 13 | 14 | 17 | 14 |
| Chronic intermittent ethanol (CIE) | 0 | 2 | 2 | 4 | 3 | 2 | 6 | 0 | 2 | 3 | 5 | 7 | 5 | 7 | 10 | 12 | 6 | 10 | 10 | 15 | 8 | 11 | 8 | 10 | 21 | 10 |
| Ketogenic diet | 0 | 1 | 0 | 2 | 3 | 0 | 0 | 0 | 3 | 1 | 1 | 1 | 4 | 3 | 4 | 10 | 3 | 3 | 7 | 9 | 10 | 13 | 8 | 11 | 10 | 16 |
| 3-Nitropropionic acid (3-NP) | 3 | 2 | 2 | 3 | 5 | 4 | 3 | 6 | 10 | 5 | 4 | 4 | 3 | 13 | 9 | 7 | 7 | 1 | 0 | 4 | 8 | 10 | 4 | 9 | 7 | 11 |
| Olfactory bulbectomy | 4 | 8 | 6 | 8 | 7 | 6 | 10 | 11 | 9 | 17 | 7 | 20 | 16 | 21 | 12 | 19 | 7 | 13 | 7 | 8 | 12 | 7 | 4 | 5 | 7 | 6 |
Each line joins an animal model's papers from 2011 to 2015, on the left, to its papers from 2021 to 2025, on the right, counting only papers that also mention a test. The gridlines step from 1 to 10, 100 and 1,000, so lines with the same slope grew at the same rate. Over the same years, all papers that mention a behavioral test grew to 1.2 times as many.
All 53 animal models. The largest and the fastest risers and fallers are named on the right.
Hover over or tap a line to see its counts, and click it to open its page. After you tab to the chart, the arrow keys step from line to line.
| Animal model | 2011 to 2015 | 2021 to 2025 | Change |
|---|---|---|---|
| Chronic unpredictable stress | 457 | 973 | 2.1 times as many |
| Exercise | 478 | 916 | 1.9 times as many |
| Lipopolysaccharide (LPS) | 313 | 876 | 2.8 times as many |
| High-fat diet | 327 | 868 | 2.7 times as many |
| Restraint stress | 412 | 553 | 1.3 times as many |
| Streptozotocin diabetes | 301 | 510 | 1.7 times as many |
| Middle cerebral artery occlusion (MCAO) | 233 | 494 | 2.1 times as many |
| Nerve injury | 388 | 485 | 1.3 times as many |
| Scopolamine | 388 | 483 | 1.2 times as many |
| Spinal cord injury | 317 | 395 | 1.2 times as many |
| Maternal separation and early-life stress | 210 | 343 | 1.6 times as many |
| Traumatic brain injury | 236 | 334 | 1.4 times as many |
| Chemotherapy drugs | 129 | 323 | 2.5 times as many |
| Carrageenan | 457 | 317 | 31% fewer |
| Ovariectomy | 322 | 309 | About the same |
| Sleep deprivation | 136 | 306 | 2.3 times as many |
| Social defeat stress | 169 | 304 | 1.8 times as many |
| Environmental enrichment | 295 | 295 | About the same |
| Social isolation | 183 | 276 | 1.5 times as many |
| Carotid artery occlusion (BCCAO, 2VO) | 174 | 264 | 1.5 times as many |
| 6-OHDA | 327 | 255 | 22% fewer |
| MPTP | 150 | 249 | 1.7 times as many |
| D-galactose | 71 | 244 | 3.4 times as many |
| Complete Freund's adjuvant (CFA) | 148 | 216 | 1.5 times as many |
| Pentylenetetrazole (PTZ) | 198 | 212 | 1.1 times as many |
| Predator stress | 228 | 206 | 10% fewer |
| MK-801 | 334 | 190 | 43% fewer |
| Streptozotocin in the brain (ICV-STZ) | 76 | 174 | 2.3 times as many |
| Gut microbiota depletion or transplant | 6 | 166 | Too few papers to compare |
| Kainic acid or pilocarpine seizures | 111 | 161 | 1.5 times as many |
| Sepsis | 26 | 161 | 6.2 times as many |
| Rotenone | 32 | 160 | 5.0 times as many |
| Aluminum chloride | 39 | 157 | 4.0 times as many |
| Prenatal valproic acid | 38 | 149 | 3.9 times as many |
| Single prolonged stress | 40 | 142 | 3.5 times as many |
| Haloperidol | 324 | 135 | 58% fewer |
| Neonatal hypoxia-ischemia | 106 | 125 | 1.2 times as many |
| Radiation exposure | 89 | 125 | 1.4 times as many |
| Calorie restriction and fasting | 68 | 120 | 1.8 times as many |
| Intracerebral hemorrhage | 65 | 114 | 1.8 times as many |
| Intermittent or chronic hypoxia | 80 | 113 | 1.4 times as many |
| Chronic corticosterone | 110 | 109 | About the same |
| Reserpine | 83 | 109 | 1.3 times as many |
| Maternal immune activation | 42 | 103 | 2.5 times as many |
| Photothrombotic stroke | 33 | 87 | 2.6 times as many |
| Cuprizone | 6 | 85 | Too few papers to compare |
| Monosodium iodoacetate | 26 | 69 | 2.7 times as many |
| Circadian disruption | 43 | 66 | 1.5 times as many |
| Subarachnoid hemorrhage | 24 | 64 | 2.7 times as many |
| Chronic intermittent ethanol (CIE) | 34 | 58 | 1.7 times as many |
| Ketogenic diet | 13 | 52 | 4.0 times as many |
| 3-Nitropropionic acid (3-NP) | 33 | 38 | 1.2 times as many |
| Olfactory bulbectomy | 76 | 35 | 54% fewer |
Each row counts the animal research papers from 2021 to 2025 that mention the animal model and at least one of the 90 behavioral tests. Each animal model's share is the percent of all its papers that mention one of those tests; for a few, we counted only papers that mention a test, so they have no share. One paper can name several species and tests, so the percents in a row can add up to more than 100.
Each animal model with 100 or more of these papers has its own page. Haloperidol is the exception: most of the papers we read give it as a comparison drug, not to produce a condition.
All 53 animal models.
| Animal model | Papers, 2021 to 2025 | Compared with 2011 to 2015 | Papers a year, 2001 to 2025 | Share of all its papers with a test | Species in the papers counted | Tests mentioned most |
|---|---|---|---|---|---|---|
| Chronic unpredictable stress Stress | 973 | 2.1 times as many | 43% |
|
| |
| Exercise Diet, sleep, exercise and housing | 916 | 1.9 times as many | 15% |
|
| |
| Lipopolysaccharide (LPS) Drugs and toxins | 876 | 2.8 times as many | Counted only with a test |
|
| |
| High-fat diet Diet, sleep, exercise and housing | 868 | 2.7 times as many | 4% |
|
| |
| Restraint stress Stress | 553 | 1.3 times as many | 36% |
|
| |
| Streptozotocin diabetes Drugs and toxins | 510 | 1.7 times as many | 6% |
|
| |
| Middle cerebral artery occlusion (MCAO) Surgery | 494 | 2.1 times as many | 11% |
|
| |
| Nerve injury Surgery | 485 | 1.3 times as many | 20% |
|
| |
| Scopolamine Drugs and toxins | 483 | 1.2 times as many | 54% |
|
| |
| Spinal cord injury Surgery | 395 | 1.2 times as many | 10% |
|
| |
| Maternal separation and early-life stress Stress | 343 | 1.6 times as many | 36% |
|
| |
| Traumatic brain injury (CCI, fluid percussion, weight drop) Surgery | 334 | 1.4 times as many | 28% |
|
| |
| Chemotherapy drugs Drugs and toxins | 323 | 2.5 times as many | Counted only with a test |
|
| |
| Carrageenan Drugs and toxins | 317 | 31% fewer | 29% |
|
| |
| Ovariectomy Surgery | 309 | about the same | 8% |
|
| |
| Sleep deprivation Diet, sleep, exercise and housing | 306 | 2.3 times as many | 28% |
|
| |
| Social defeat stress Stress | 304 | 1.8 times as many | 39% |
|
| |
| Environmental enrichment Diet, sleep, exercise and housing | 295 | about the same | 39% |
|
| |
| Social isolation Stress | 276 | 1.5 times as many | 43% |
|
| |
| Carotid artery occlusion (BCCAO, 2VO) Surgery | 264 | 1.5 times as many | 39% |
|
| |
| 6-OHDA Drugs and toxins | 255 | 22% fewer | 25% |
|
| |
| MPTP Drugs and toxins | 249 | 1.7 times as many | 20% |
|
| |
| D-galactose Drugs and toxins | 244 | 3.4 times as many | 24% |
|
| |
| Complete Freund's adjuvant (CFA) Drugs and toxins | 216 | 1.5 times as many | 21% |
|
| |
| Pentylenetetrazole (PTZ) Drugs and toxins | 212 | 1.1 times as many | 20% |
|
| |
| Predator stress Stress | 206 | 10% fewer | 81% |
|
| |
| MK-801 Drugs and toxins | 190 | 43% fewer | 49% |
|
| |
| Streptozotocin in the brain (ICV-STZ) Drugs and toxins | 174 | 2.3 times as many | 61% |
|
| |
| Gut microbiota depletion or transplant Diet, sleep, exercise and housing | 166 | Too few papers to compare | 5% |
|
| |
| Kainic acid or pilocarpine seizures Drugs and toxins | 161 | 1.5 times as many | 14% |
|
| |
| Sepsis Surgery | 161 | 6.2 times as many | 7% |
|
| |
| Rotenone Drugs and toxins | 160 | 5.0 times as many | 30% |
|
| |
| Aluminum chloride Drugs and toxins | 157 | 4.0 times as many | 31% |
|
| |
| Prenatal valproic acid Drugs and toxins | 149 | 3.9 times as many | 29% |
|
| |
| Single prolonged stress Stress | 142 | 3.5 times as many | 63% |
|
| |
| Haloperidol Drugs and toxins | 135 | 58% fewer | Counted only with a test |
|
| |
| Neonatal hypoxia-ischemia Surgery | 125 | 1.2 times as many | 19% |
|
| |
| Radiation exposure Drugs and toxins | 125 | 1.4 times as many | Counted only with a test |
|
| |
| Calorie restriction and fasting Diet, sleep, exercise and housing | 120 | 1.8 times as many | 8% |
|
| |
| Intracerebral hemorrhage Surgery | 114 | 1.8 times as many | 11% |
|
| |
| Intermittent or chronic hypoxia Diet, sleep, exercise and housing | 113 | 1.4 times as many | 8% |
|
| |
| Chronic corticosterone Drugs and toxins | 109 | about the same | 32% |
|
| |
| Reserpine Drugs and toxins | 109 | 1.3 times as many | 44% |
|
| |
| Maternal immune activation Drugs and toxins | 103 | 2.5 times as many | 28% |
|
| |
| Photothrombotic stroke Surgery | 87 | 2.6 times as many | 24% |
|
| |
| Cuprizone Drugs and toxins | 85 | Too few papers to compare | 18% |
|
| |
| Monosodium iodoacetate Drugs and toxins | 69 | 2.7 times as many | 19% |
|
| |
| Circadian disruption Diet, sleep, exercise and housing | 66 | 1.5 times as many | Counted only with a test |
|
| |
| Subarachnoid hemorrhage Surgery | 64 | 2.7 times as many | 10% |
|
| |
| Chronic intermittent ethanol (CIE) Diet, sleep, exercise and housing | 58 | 1.7 times as many | 42% |
|
| |
| Ketogenic diet Diet, sleep, exercise and housing | 52 | 4.0 times as many | 11% |
|
| |
| 3-Nitropropionic acid (3-NP) Drugs and toxins | 38 | 1.2 times as many | 28% |
|
| |
| Olfactory bulbectomy Surgery | 35 | 54% fewer | 57% |
|
|
Besides haloperidol, the 9 animal models without a link each have fewer than 100 of these papers.
A paper counts when it is animal research and its title or abstract mentions one of an animal model's search terms and one of the 90 behavioral tests. A count is a number of papers, not of experiments, labs or animals. A paper that mentions the animal model only in its methods is missed, so the counts run low.
Each model has its own search terms, matched as whole words, with rules that skip other meanings. Streptozotocin given into the brain counts apart from streptozotocin that causes diabetes, and CFA counts as a pain model only in papers that name neither EAE nor immunization. A paper is animal research when its MeSH terms name an animal species. If they name none, NCBI's text-mining service PubTator 3 has to find one in the title or abstract. Papers on animals other than mice, rats, zebrafish, flies and primates count only when they also mention a test. Many of them study people or use the same words for something else. A paper can count under more than one animal model.
The search terms for each animal model are in the downloads below. The full method, with each source and its terms of use, is on our main page, Behavioral tests in published research.
Each file covers both the animal models and the brain techniques. These files are part of the data set "Behavioral tests in published research." To download them, add the data set to a ConductScience account. The data set and the account are free. You may reuse the files with credit, under CC BY 4.0.
One row per model or technique: its papers in each period, those that also mention a test, their species and the search terms.
CSV
One row per model or technique and year, with its papers and those that also mention a test.
CSV
One row for each model or technique an animal paper mentions, by PubMed ID, with the tests it mentions, its species and disease models.
CSV, compressed
One row per model or technique and test, with the papers from 2021 to 2025 that mention both.
CSV
ConductScience.org is our site for research data, lab notebooks and journals. One ConductScience account signs you in on both sites.
Upload a data set with its description. A person reviews it before it is published.
Record your experiments as entries you can sign and amend. Write a paper from those entries.
Look up a gene, a drug, a trial or a disease. Each database names its source and the day it was last counted.
ConductScience. (2026, November 13). Animal models in behavioral research [Data set]. https://conductscience.com/data/animal-models
@misc{conductscience_animal_models_2026,
author = {{ConductScience}},
title = {Animal models in behavioral research},
year = {2026},
month = nov,
url = {https://conductscience.com/data/animal-models},
note = {Data set, released November 13, 2026},
}Our store sells equipment for many of these animal models.